News | Computed Tomography (CT) | July 20, 2020

Canon Introduces New Aquilion One Genesis SP Cardiac CT Scanner

Solution powered by artificial intelligence and offers innovative cardiac image capabilities 

The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images. #SCCT2020

The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images.

July 20, 2020 – To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA is introducing a new configuration of the Aquilion One / Genesis Edition – the Aquilion One / Genesis SP. The vendor said this is a complete cardiac CT solution that is designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its artificial intelligence (AI)-powered, wide-area CT.

Canon Aquilion One Genesis SP cardiac CT scanner. #SCCT20The Aquilion One / Genesis SP enhances Canon Medical’s suite of collaborative imaging tools which deliver clarity and confidence across the patient care cycle. Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process, from evaluation to treatment, offering a wide range of features for complete cardiac care. These features include: 
   • Improved diagnostic confidence across patients with one-beat, whole-heart acquisition and advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), which enables clinicians to obtain sharp, clear and distinct images. 
   • Enhanced workflow capabilities because of automated tools from acquisition through analysis such as SURECardio and Vitrea advanced visualization, which can help clinicians manage their new increase in patient volume, and also deliver proven consistency in high image quality. 
   • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and power save mode improvements that enable the Aquilion One Genesis / SP to require less cost to operate.
   • Patient-centric enhancements to help improve safety, comfort and access, including a wide bore (78 cm) and wide (47 cm) and low (33 cm) couch.

“Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. At Canon Medical, we are committed to providing technologies that help clinicians keep pace with these evolving clinical pathways,” said Erin Angel, managing director, CT business unit, Canon Medical Systems USA Inc. “Canon Medical’s CT product line, including the Aquilion One / Genesis SP, is designed to offer complete cardiac capabilities. The platform was designed to be intuitive, making the acquisition of high quality images easy and reliable across the full spectrum of patients and clinical scenarios.”

Canon Medical is showcased the new CT system and its full suite of icardiac capabilities at the Society of Cardiac Computed Tomography (SCCT) 2020 virtual annual meeting. People can visit Canon's virtual booth at https://us.medical.canon/go/PR_7-2020_GENESIS_SP

For more information: https://us.medical.canon

Related Content

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.
C-RAD has been selected as the partner to implement surface tracking technology for three proton cancer treatment centers in the U.S.
News | Proton Therapy | December 28, 2020
December 28, 2020 — C-RAD offers a specific version of its Catalyst System for use in...
The key trends oClinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | December 17, 2020 | By Melinda Taschetta-Millane and Dave Fornell
Post-neoadjuvant therapy changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma

Pre-treatment (A-C) and post-treatment (D-F) images after eight cycles of systemic FOLFIRINOX and consolidative chemoradiation. Baseline CA 19-9 was 145 U/ml. Pre-treatment whole body axial fused PET/MRI showed FDG avid lesion in body of pancreas (arrow, A) with SUVmax 7.1 and SUVgluc 8.0. Lesion was hypo-enhancing on axial contrast-enhanced T1-weighted (T1W) MR image (arrow, B) from focused abdominal PET/MRI and on CT (arrow, C). Pre-treatment CT tumor volume was 10.3 cm3. Post-treatment whole body axial fused PET/MRI showed complete metabolic response (arrow D) with SUVmax 1.9 and SUVgluc 1.9. Lesion was indistinct on axial contrast-enhanced T1W MRI (arrow, E) and CT (arrow, F), and there was upstream pancreatic parenchymal atrophy. Post-treatment CT tumor volume was 0.46 cm3. There was normalization of CA 19-9. Relative change in SUVmax (ΔSUVgluc) was -73%, and relative change in SUVgluc (ΔSUVgluc) was -76%. Based on change in tumor size, response was categorized as partial response per RECIST. Relative change in tumor volume (ΔTvol) was -96%. Pathology showed major pathologic response (College of American Pathologists score 1.) Images courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | PET-MRI | December 10, 2020
December 10, 2020 — According to an open...
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19
Earlier initial diagnosis reduces lung cancer mortality in heavy (ex-)smokers / The risk of harm from misdiagnosis or overdiagnosis is relatively low

Image courtesy of Toshiba/Canon

News | Computed Tomography (CT) | December 08, 2020
December 8, 2020 — For heavy (ex-)smokers,...
The company’s ClearRead Xray Confirm (Enhanced) and ClearRead CT – breakthrough lung nodule detection applications­ – have received clearance for sale in Australia
News | Computed Tomography (CT) | December 03, 2020
December 3, 2020 — Riverain Technologies, a U.S.-based developer of...
Advanced imaging with computed tomography (CT) shows that people who cook with biomass fuels like wood are at risk of suffering considerable damage to their lungs from breathing in dangerous concentrations of pollutants and bacterial toxins, according to a study being presented at the annual meeting of the Radiological Society of North America (RSNA).

Kitchen location showing the cooking stove and wood fuels used; there is a lack of sufficient ventilation to clear the smoke by-products from biomass fuel use. Image courtesy of Radiological Society of North America

News | Computed Tomography (CT) | December 03, 2020
December 3, 2020 — Advanced imaging with comput...